Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic
CONCLUSION: Over 80% of patients received their on-time second dose of mRNA-1273 vaccine per CDC recommendations. Patient demographics and community characteristics were associated with vaccine receipt and series completion. Novel approaches to facilitate series completion during a pandemic should be further studied.PMID:37296016 | PMC:PMC10172969 | DOI:10.1016/j.vaccine.2023.03.076
Source: Vaccine - Category: Allergy & Immunology Authors: Erin Roberts-McCarthy Philip O Buck Renae L Smith-Ray Nicolas Van de Velde Tanya Singh James Mansi Amy Shah Michael Taitel Source Type: research
More News: Allergy & Immunology | Coronavirus | Covid Vaccine | COVID-19 | Emergency Medicine | Health Insurance | Insurance | Pandemics | Pfizer | Respiratory Medicine | SARS | Study | USA Health | Vaccines